ArticleOncoTargets and therapy

Erratum: Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.